Correction: HOTAIR regulates HK2 expression by binding endogenous miR-125 and miR-143 in oesophageal squamous cell carcinoma progression

Jian Ma; Yanxin Fan; Tingting Feng; Fangjun Chen; Zhipeng Xu; Suqing Li; Qingfeng Lin; Xiaoting He; Weihong Shi; Yang Liu; Zhihua Liu; Bin Zhu; Xiufeng Cao

doi:10.18632/oncotarget.26801

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Corrections:

Correction: HOTAIR regulates HK2 expression by binding endogenous miR-125 and miR-143 in oesophageal squamous cell carcinoma progression

PDF | How to cite

Oncotarget. 2019; 10:2112-2112. https://doi.org/10.18632/oncotarget.26801

Metrics: PDF 1342 views | ?

Jian Ma^1,*, Yanxin Fan^2,*, Tingting Feng^1,3,*, Fangjun Chen⁴, Zhipeng Xu¹, Suqing Li¹, Qingfeng Lin¹, Xiaoting He¹, Weihong Shi^1,5, Yang Liu⁶, Zhihua Liu⁷, Bin Zhu¹ and Xiufeng Cao¹

¹ Department of Surgical Oncology, Nanjing First Hospital, Nanjing Medical University, Nanjing 210008, Jiangsu Province, China
² Jiangsu Cancer Hospital, Medical School of Nanjing University, Nanjing 210008, Jiangsu Province, China
³ Institute of Biology and Medical Sciences, Jiangsu Key Laboratory of Infection and Immunity, Soochow University, Suzhou 215123, Jiangsu Province, China
⁴ The Comprehensive Cancer Centre of Drum Tower Hospital, Medical School of Nanjing University, Clinical Cancer Institute of Nanjing University, Nanjing 210008, Jiangsu Province, China
⁵ Yancheng Vocational Institute of Health Sciences, Yancheng 224005, Jiangsu Province, China
⁶ Department of Pharmacy, No.401 Hospital of Chinese People’s Liberation Army, Qingdao 266071, Shandong Province, China
⁷ State Key Laboratory of Molecular Oncology, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences, Beijing 100021, China
^* These authors have contributed equally to this work

Published: March 12, 2019

This article has been corrected: The correct affiliation information is given below:

¹ Department of Surgical Oncology, Nanjing First Hospital, Nanjing Medical University, Nanjing 210008, Jiangsu Province, China

Original article: Oncotarget. 2017; 8:86410-86422. DOI: https://doi.org/10.18632/oncotarget.21195.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 26801

Publication Alerts

Corrections:

Correction: HOTAIR regulates HK2 expression by binding endogenous miR-125 and miR-143 in oesophageal squamous cell carcinoma progression